Start 30 days free, no card. Full Pro access for a month, then decide. Start free
Analyst
Susan Anderson
Period: Reporting periods mapped to calendar 2025 Q2 – 2026 Q3 (6 quarters; questions recorded in 4).
- Questions
- 4on tracked calls
- Challenge rate
- 0%none of 4 questionsLimited sample
- Companies
- 1questioned at least once
- Reporting periods
- 4with questions
These figures cover the whole profile: every tracked question, all reporting periods.
How to read these numbers
Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.
Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.
No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.
Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.
Small samples. Profiles with fewer than 10 questions are marked Limited sample.
Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.
Questions asked
Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.
Showing 4 of 4 questions from 1 company
ULTAUlta Beauty4 questions · 4 reporting periods · 0 of 4 challenging
Calendar 2026 Q3
how do you balance the investment between the 2 categories?
Show response
CEO expressed confidence in balanced back-half newness and framed mass (roughly 30% of the business) as a discovery and exclusives play versus prestige (roughly 70%, where Ulta gained share), downplaying pure-price mass competition.
Calendar 2026 Q1
I was wondering maybe if you could talk about the timing of the new DC in the Northwest. And I guess how should we think about the cost there?
Show response
Kecia confirmed new Northwest DC not operational until 2027, construction costs already in CapEx guidance. Chris explained H2 margin improvement driven by lapping Space NK acquisition and annualizing H2 2025 investments plus holiday leverage.
Calendar 2025 Q3
I don't know if you could talk about Space NK and just the thought process around buying another retailer to expand internationally versus using your own Ulta stores?
Show response
Kecia explained three international expansion modes (license/franchise, JV, acquisition). Space NK provides less capital-intensive entry. Learning opportunity from high-street, prestige-focused model.
Calendar 2025 Q2
I was wondering if you can maybe just talk about the newness and innovation pipeline as we kinda head in through the summer into the back half
Show response
Kecia confirmed strong pipeline but declined to share specifics. Emphasized cross-category balance and exclusivity blend without naming upcoming brands.
Challenge rate by company
Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.
| Company | Questions | Challenge rate |
|---|---|---|
| ULTA Ulta Beauty | 4 | 0%none of 4 questions |
- ULTAUlta Beauty · 4 questions0%none of 4 questions
Activity by reporting period
Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.
| Calendar period | Questions | Challenge rate | Companies |
|---|---|---|---|
| 2025 Q2 | 1 | 0%none of 1 question | 1 |
| 2025 Q3 | 1 | 0%none of 1 question | 1 |
| 2025 Q4 | No questions recorded | — | — |
| 2026 Q1 | 1 | 0%none of 1 question | 1 |
| 2026 Q2 | No questions recorded | — | — |
| 2026 Q3 | 1 | 0%none of 1 question | 1 |
- 2025 Q21 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q31 question · challenge rate 0% (none of 1 question) · 1 company
- 2025 Q4No questions recorded
- 2026 Q11 question · challenge rate 0% (none of 1 question) · 1 company
- 2026 Q2No questions recorded
- 2026 Q31 question · challenge rate 0% (none of 1 question) · 1 company
Topics
Topics tagged on this analyst’s questions.
- Product Launch2
- Competitive Dynamics1
- Capex Investment1
- Margin1
- M&A1
- Geographic Expansion1
- Innovation & R&D1